Levodopa-related motor complications--phenomenology
- PMID: 18781677
- DOI: 10.1002/mds.22021
Levodopa-related motor complications--phenomenology
Abstract
Long term levodopa therapy in Parkinson's disease (PD) results in a range of problems. These include fluctuations in FD symptoms termed motor fluctuations, as well as non-motor symptoms, termed non-motor fluctuations. Here we review the phenomenology and methods of assessing these levodopa-related complications.
(c) 2008 Movement Disorder Society.
Similar articles
-
Treatment of levodopa-induced motor complications.Mov Disord. 2008;23 Suppl 3:S599-612. doi: 10.1002/mds.22052. Mov Disord. 2008. PMID: 18781681 Review.
-
Recognition and treatment of response fluctuations in Parkinson's disease: review article.Amino Acids. 2002;23(1-3):141-5. doi: 10.1007/s00726-001-0119-1. Amino Acids. 2002. PMID: 12373528 Review.
-
Role of integrative pharmacokinetic and pharmacodynamic optimization strategy in the management of Parkinson"s disease patients experiencing motor fluctuations with levodopa.J Pharm Pharm Sci. 2002 May-Aug;5(2):146-61. J Pharm Pharm Sci. 2002. PMID: 12207867
-
Levodopa unresponsive symptoms in Parkinson disease.Mov Disord. 2008;23 Suppl 3:S521-33. doi: 10.1002/mds.22049. Mov Disord. 2008. PMID: 18781679 Review.
-
Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.J Clin Neurosci. 2009 Aug;16(8):1034-7. doi: 10.1016/j.jocn.2008.10.015. Epub 2009 May 9. J Clin Neurosci. 2009. PMID: 19428256
Cited by
-
Tremor in Parkinson's Disease: From Pathophysiology to Advanced Therapies.Tremor Other Hyperkinet Mov (N Y). 2022 Sep 13;12:29. doi: 10.5334/tohm.712. eCollection 2022. Tremor Other Hyperkinet Mov (N Y). 2022. PMID: 36211804 Free PMC article. Review.
-
Parallel dopamine D1 receptor activity dependence of l-Dopa-induced normal movement and dyskinesia in mice.Neuroscience. 2013 Apr 16;236:66-76. doi: 10.1016/j.neuroscience.2012.12.065. Epub 2013 Jan 26. Neuroscience. 2013. PMID: 23357114 Free PMC article.
-
Methylphenidate : a treatment for Parkinson's disease?CNS Drugs. 2013 Jan;27(1):1-14. doi: 10.1007/s40263-012-0017-y. CNS Drugs. 2013. PMID: 23160937
-
Optimizing Clinical Assessments in Parkinson's Disease Through the Use of Wearable Sensors and Data Driven Modeling.Front Comput Neurosci. 2018 Sep 11;12:72. doi: 10.3389/fncom.2018.00072. eCollection 2018. Front Comput Neurosci. 2018. PMID: 30254580 Free PMC article. Review.
-
Remnants of Cardinal Symptoms of Parkinson's Disease, Not Dyskinesia, Are Problematic for Dyskinetic Patients Performing Activities of Daily Living.Front Neurol. 2019 Mar 22;10:256. doi: 10.3389/fneur.2019.00256. eCollection 2019. Front Neurol. 2019. PMID: 30967832 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources